Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | AMDHD2 | Q9Y303 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | SERPINC1 | P01008 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 4/20 | 0.36 |
| ▸ | FGF1 | P05230 | 1/20 | 0.33 |
| ▸ | FGF2 | P09038 | 1/20 | 0.33 |
| ▸ | HK2 | P52789 | 5/20 | 0.32 |
| ▸ | HK1 | P19367 | 4/20 | 0.32 |
| ▸ | FBP1 | P09467 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 3/20 | 0.30 |
| ▸ | CA1 | P00915 | 3/20 | 0.30 |
| ▸ | CA9 | Q16790 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13286928 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL21067663 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL20987120 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL7209912 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL1009127 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL16728926 | 1.00 | F10 (0.42) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL15449484 | 0.87 | F10 (0.36) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL29535532 | 0.85 | F10 (0.48) | F10F2SERPINC1FGF1FGF2 | |
| SCHEMBL29534894 | 0.85 | F10 (0.43) | F10AMDHD2F2SERPINC1CA2 | |
| SCHEMBL17340086 | 0.82 | F10 (0.57) | F10SERPINC1CA2FGF1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2805930-B1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | CORNING INC (US) | 2017-11-01 | — | — | EP | disclosed |
| US-9707155-B2 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | CORNING INCORPORATED (US) | 2017-07-18 | — | — | US | disclosed |
| US-20150140598-A1 | Methods of Screening Sulfated Polysaccharides for Therapeutic Activity for a Glycocalyx-Related Disease | DANIELS BRUCE A (US) | 2015-05-21 | — | — | US | disclosed |
| EP-2805930-A1 | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients | Corning Incorporated (US) | 2014-11-26 | — | — | EP | disclosed |
| US-20140341891-A1 | DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS | CORNING INCORPORATED (US) | 2014-11-20 | — | — | US | disclosed |
| EP-2766025-A1 | THERAPEUTIC SULFATED POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS FOR TREATING PATIENTS | Daniels, Bruce A. (US) | 2014-08-20 | — | — | EP | disclosed |
| US-20140046052-A1 | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients | DANIELS BRUCE A (US) | 2014-02-13 | — | — | US | disclosed |
| US-20130273096-A1 | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients | DANIELS BRUCE A (US) | 2013-10-17 | — | — | US | disclosed |
| WO-2013052899-A1 | THERAPEUTIC SULFATED POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS FOR TREATING PATIENTS | DANIELS BRUCE A (US) | 2013-04-11 | — | — | WO | disclosed |
| EP-0862581-B1 | HEPARIN CHROMATOGRAPHY OF ERYTHROPOIETINS | AVENTIS PHARMA INC (US) | 2003-06-04 | — | — | EP | disclosed |
| US-6461844-B1 | PHOSPHORYLATES N-ACETYLGALACTOSAMINE; FROM PIG KIDNEYS AND LIVERS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS | 2002-10-08 | — | — | US | disclosed |
| EP-0862581-A1 | HEPARIN CHROMATOGRAPHY OF ERYTHROPOIETINS | HOECHST MARION ROUSSEL, INC. (US) | 1998-09-09 | — | — | EP | disclosed |
| WO-1997017366-A1 | HEPARIN CHROMATOGRAPHY OF ERYTHROPOIETINS | HOECHST MARION ROUSSEL, INC. (US) | 1997-05-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130273096-A1 | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients | DDOST, CSGALNACT1, GYS2 | F10 703/4885AMDHD2 1092/4885F2 511/4885 |
| US-20140046052-A1 | Therapeutic Sulfated Polysaccharides, Compositions Thereof, and Methods for Treating Patients | DDOST, CSGALNACT1, GYS2 | F10 703/4885AMDHD2 1092/4885F2 511/4885 |
| US-20140341891-A1 | DELAMINATION RESISTANT PHARMACEUTICAL GLASS CONTAINERS CONTAINING ACTIVE PHARMACEUTICAL INGREDIENTS | SIGLEC7, GYPA, NECTIN4 | F10 1088/4885AMDHD2 3127/4885F2 3299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.